cronos group glp-1 receptor agonists weight management diabetes treatments agonist Frontiers The Unstoppable Rise of GLP-1
Description
BMI 30 kg/m2 (obese class I)
In simple terms, it acts as if there is more GLP-1 in circulation
3337 In individuals with HFrEF, GLP-1 RAs do not affect LV systolic function, whereas the effects of GLP-1 RAs in individuals with HFpEF have not yet been investigated
2013 Jun;123(6):2730-6
What is the pipeline for future medications for obesity
